REQUEST A DEMO
Total
USD $0.00
Search more companies

Baumpharma Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Baumpharma Sas Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Baumpharma Sas is based in Colombia, with the head office in Bogota D.C.. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on February 28, 2019. It currently has a total number of 2 (2023) employees. The latest financial highlights indicate a net sales revenue drop of 12.21% in 2022. There was a total growth of 9.24% in Baumpharma Sas’s total assets over the same period. The net profit margin of Baumpharma Sas decreased by 7.02% in 2022.

Headquarters
Carrera 16 55 48 Piso 2
Bogota D.C.; Bogota D.C; Postal Code: 0210

Contact Details: Purchase the Baumpharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Baumpharma Sas report to view the information.
Outstanding Shares:
Purchase the Baumpharma Sas report to view the information.
Incorporation Date:
February 28, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Baumpharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-12.21%
Total operating revenue
-12.21%
Operating profit (EBIT)
-59.19%
Net Profit (Loss) for the Period
-84.11%
Total assets
9.24%
Total equity
3.6%
Operating Profit Margin (ROS)
-6.65%
Net Profit Margin
-7.02%
Return on Equity (ROE)
-35.97%
Quick Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?